Point72 Asset Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145M | Buy |
|
|||||
|
2025
Q1 | $20.6M | Sell |
|
|||||
|
2024
Q4 | $25M | Sell |
|
|||||
|
2024
Q3 | $37.4M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $7.3M | Sell |
|
|||||
|
2023
Q4 | $15M | Buy |
|
|||||
|
2023
Q3 | $1.95M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $21.7M | Buy |
|
|||||
|
2022
Q1 | $26.2M | Buy |
|
|||||
|
2021
Q4 | $37.2M | Buy |
|
|||||
|
2021
Q3 | $31.3M | Buy |
|
|||||
|
2021
Q2 | $29.6M | Buy |
|
|||||
|
2021
Q1 | $14.7M | Sell |
|
|||||
|
2020
Q4 | $18.2M | Buy |
|
|||||
|
2020
Q3 | $4.41M | Sell |
|
|||||
|
2020
Q2 | $11.1M | Sell |
|
|||||
|
2020
Q1 | $15.4M | Buy |
|
|||||
|
2019
Q4 | $5.02M | Buy |
|
|||||
|
2019
Q3 | $2.43M | Buy |
|
|||||
|
2019
Q2 | $575K | Buy |
|